Related Experiment Video

Updated: Jun 24, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis

Oscar-Danilo Ortega-Hernandez1, Ricardo Pineda-Tamayo, Aryce L Pardo

  • 1Center for Autoimmune Diseases Research (CREA), School of Medicine, Rosario University, Carrera 24 # 63-C-69, Corporacion para Investigaciones Biológicas, Bogota, Colombia.

Clinical Rheumatology
|March 12, 2009
PubMed

Insights

Longer disease duration and high anti-CCP antibody titers are linked to extra-articular rheumatoid arthritis (ExRA) in Colombian patients. Smoking prevention is crucial for those at risk of rheumatoid arthritis and related autoimmune diseases.

Area of Science:

  • Rheumatology
  • Clinical Immunology
  • Genetics

Background:

  • Extra-articular rheumatoid arthritis (ExRA) encompasses rheumatoid arthritis (RA) manifestations beyond the joints.
  • Understanding ExRA's clinical and genetic associations is vital for patient management and risk stratification.

Purpose of the Study:

  • To investigate clinical and genetic factors associated with extra-articular rheumatoid arthritis (ExRA) in a Colombian RA patient cohort.
  • To identify predictors and protective factors for ExRA development.

Main Methods:

  • Cross-sectional study of 538 Colombian patients with rheumatoid arthritis (RA).
  • Data collection included demographics, clinical characteristics, inflammatory markers, comorbidities, cardiovascular risk factors, and familial autoimmunity history.
  • Assessment of HLA "shared epitope" (SE) alleles and TNF gene polymorphism.
  • Multivariate statistical analysis was employed.

Main Results:

  • Extra-articular rheumatoid arthritis (ExRA) was present in 32% of patients, with nodulosis (21%), Sjögren's syndrome (9%), and lung involvement (4%) being common.
  • Patients with ExRA were older and had longer disease duration.
  • Higher anti-CCP antibody titers, hypertension, and thrombosis were significantly associated with ExRA.
  • Never smoking was identified as a protective factor against ExRA onset.

Conclusions:

  • Disease duration, cardiovascular disease, and high anti-CCP antibody titers are key associations with ExRA in Colombian RA patients.
  • Preventing smoking is important for individuals susceptible to autoimmune diseases, including RA.
  • Identifying ExRA predictors aids in targeted interventions and improved patient outcomes.

More Related Videos

Automated Joint Space Detection Improves Bone Segmentation Accuracy06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...